N-(4-Methoxyphenyl)-1-(quinolin-8-ylsulfonyl)piperidine-4-carboxamide
98%
- Product Code: 215601
CAS:
909856-86-6
Molecular Weight: | 425.5 g./mol | Molecular Formula: | C₂₂H₂₃N₃O₄S |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | 1.352±0.06 g/cm3(Predicted) | Storage Condition: | Room temperature, seal, dry |
Product Description:
Used in pharmaceutical research as a key intermediate in the development of kinase inhibitors, particularly targeting tyrosine kinases involved in cancer cell proliferation. Shows potential in modulating signaling pathways in oncology studies. Also employed in the synthesis of bioactive molecules for evaluating anti-tumor activity in preclinical models. Its structural features support high binding affinity to specific enzyme targets, making it valuable in structure-activity relationship (SAR) studies.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
100mg | 10-20 days | €401.37 |
+
-
|
250mg | 10-20 days | €681.75 |
+
-
|
N-(4-Methoxyphenyl)-1-(quinolin-8-ylsulfonyl)piperidine-4-carboxamide
Used in pharmaceutical research as a key intermediate in the development of kinase inhibitors, particularly targeting tyrosine kinases involved in cancer cell proliferation. Shows potential in modulating signaling pathways in oncology studies. Also employed in the synthesis of bioactive molecules for evaluating anti-tumor activity in preclinical models. Its structural features support high binding affinity to specific enzyme targets, making it valuable in structure-activity relationship (SAR) studies.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
€0.00
€0.00
Total :